Establishment Labs Holdings (ESTA) Shareholder's Equity (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.22% |
| Dec 31, 2025 | 43.90% |
| Sep 30, 2025 | -28.12% |
| Jun 30, 2025 | -40.95% |
| Mar 31, 2025 | -27.39% |
| Dec 31, 2024 | 62.32% |
| Sep 30, 2024 | -27.34% |
| Jun 30, 2024 | -20.90% |
| Mar 31, 2024 | 209.38% |
| Dec 31, 2023 | -39.66% |
| Sep 30, 2023 | -44.44% |
| Jun 30, 2023 | 443.04% |
| Mar 31, 2023 | -95.43% |
| Dec 31, 2022 | -638.84% |
| Sep 30, 2022 | -90.43% |
| Jun 30, 2022 | -66.83% |
| Mar 31, 2022 | -5.72% |
| Dec 31, 2021 | -17.58% |
| Sep 30, 2021 | -10.56% |
| Jun 30, 2021 | -5.13% |
| Mar 31, 2021 | -3.22% |
| Dec 31, 2020 | -6.26% |
| Sep 30, 2020 | -2.23% |
| Jun 30, 2020 | -9.44% |
| Mar 31, 2020 | 127.98% |
| Dec 31, 2019 | -9.57% |
| Sep 30, 2019 | -18.56% |
| Jun 30, 2019 | -11.87% |
| Mar 31, 2019 | -12.17% |
| Dec 31, 2018 | -9.74% |
| Sep 30, 2018 | 3,147.03% |
| Jun 30, 2018 | 127.07% |
| Mar 31, 2018 | -74.75% |
| Dec 31, 2017 | -54.29% |
| Sep 30, 2017 | 85.51% |